• SENSEX 76,024.51
    -1,390.41 (--1.80%)
  • BANKNIFTY 50,827.50
    -737.35 (--1.43%)
  • Vodafone Idea
    8.57 19.15(%)
  • Hind.Aeronautics
    4,492.80 5,675.00(%)
  • HBL Engineering
    532.15 738.65(%)
  • Reliance Industr
    1,250.00 1,156.00(%)
  • HDFC Bank
    1,765.00 1,430.15(%)
  • Galaxy Surfact.
    2,096.20 3,366.30(%)
  • Adani Green
    916.95 758.00(%)
  • ICICI Bank
    1,315.00 1,048.35(%)
  • Zomato Ltd
    205.00 304.50(%)
  • Larsen & Toubro
    3,430.60 3,141.30(%)
  • Infosys
    1,518.00 1,359.10(%)
  • Bajaj Finance
    8,672.00 6,376.55(%)
  • Dixon Technolog.
    12,880.05 7,100.05(%)
  • IndusInd Bank
    689.85 1,576.00(%)
  • ITC
    405.50 381.24(%)
  • Nip. India Gold
    77.05 77.05(%)
  • St Bk of India
    763.05 679.65(%)
  • M & M
    2,625.00 1,891.30(%)
  • Trent
    5,619.85 8,345.85(%)
  • PB Fintech.
    1,505.90 1,110.25(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Aurobindo Pharma Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 4666.0
  • ISIN : INE406A01037
1,134.15 -26 (-2.27%)
  • As on 02 Apr 2025 (EOD)

  • Today’s Low

    1,126.45

  • Today’s High

    1,186.20

  • Open

    1,156.50

  • Perv Close

    1,160.50

  • 52W Low

    1,031.05

  • 52W High

    1,592.00

Key Indicators

  • P/E(TTM)

    34.68

  • Mar.Cap (₹Cr.)

    66,454.23

  • Div & Yield %

    0.40

  • Book Value(₹)

    335.47

  • Debt-Equity Ratio

    -2.27

  • AGM Date

    01-Apr-2025

  • EPS

    32.72

  • P/E Ratio

    34.68

Financials Ratios

  • Debt-Equity Ratio

    0.21

  • Mar.Cap (₹Cr.)

    66,454.23

  • RONW (%)

    11.18

  • ROCE (%)

    13.51

Score Board

  • Equity (₹ in Cr.)

    58.59

  • BV (₹)

    335.50

  • Sales( ₹ in Cr.)

    10,645.64

  • NP (in Cr.)

    1,952.97

  • NP Var(%)

    60.0

  • Div%

    450.0

  • CPS (₹)

    37.70

  • EPS (₹)

    33.30

  • Traded Value (₹ in Lakhs)

    66,495.24

  • 52 Week High

    1,592.00

  • 52 Week Low

    1,031.05

  • Price BSE

    1135.0

  • Price NSE

    1,134.00

  • Market Capital( in Cr.)

    66,495.24

  • P/C Ratio

    30.10

  • P/E Ratio

    34.10

  • Price Vs.BV

    33.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 10,645.64 8,457.00 11,287.14 15,823.68 13,370.77 12,257.89
Excise Duty 10,270.85 8,171.01 11,059.49 15,610.73 13,021.94 11,922.63
Net Sales 10,645.64 8,457.00 11,287.14 15,823.68 13,370.77 12,257.89
Other Income 616.06 443.92 670.99 589.86 388.79 199.22
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 11,261.70 8,900.92 11,958.13 16,413.54 13,759.56 12,457.11
EXPENDITURE :
Raw Materials 10,270.85 8,171.01 11,059.49 15,610.73 13,021.94 11,922.63
Power & Fuel Cost 10,270.85 8,171.01 11,059.49 15,610.73 13,021.94 11,922.63
Employee Cost 980.56 890.53 1,600.04 1,735.42 1,577.14 1,362.77
Other Manufacturing Expenses 164.49 133.90 174.42 215.57 235.47 218.09
Selling & Administrative Expenses 822.21 939.38 1,009.36 1,069.84 938.36 786.90
Miscellaneous Expenses 164.49 133.90 174.42 215.57 235.47 218.09
Less : Pre-operative Expenses Capitalised :
Total Expenditure 8,858.78 7,269.93 10,245.94 12,220.53 11,389.51 10,492.49
Operating Profit 606.09 496.28 1,183.67 1,438.20 1,340.75 1,301.09
Interest 182.60 74.58 16.94 28.68 243.28 230.86
Gross Profit 2,402.92 1,630.99 1,637.48 4,193.01 2,370.05 1,964.62
Depreciation 254.58 243.26 415.26 488.00 473.33 413.03
Profit Before Tax 2,402.92 1,630.99 1,637.48 4,193.01 2,370.05 1,964.62
Tax 598.08 412.16 379.70 1,043.34 492.28 426.61
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -95.26 -23.34 -196.93 36.76 0.89 56.33
Reported Net Profit 1,900.10 1,242.17 1,454.71 3,112.91 1,876.88 1,529.73
Extraordinary Items 2,402.92 1,630.99 1,637.48 4,193.01 2,370.05 1,964.62
Adjusted Net Profit 1,900.10 1,242.17 1,454.71 3,112.91 1,876.88 1,529.73
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 72.49 -19.76 0.00 0.00 0.00 0.00
Statutory Appropriations 263.66 439.45 527.34 234.37 175.78 146.48
P & L Balance carried down 1,900.10 1,242.17 1,454.71 3,112.91 1,876.88 1,529.73
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 450.00 750.00 900.00 400.00 300.00 250.00
Dividend Per Share(Rs) 4.50 7.50 9.00 4.00 3.00 2.50
Earnings Per Share-Unit Curr 33.35 20.94 24.83 53.13 32.03 26.11
Book Value 263.66 439.45 527.34 234.37 175.78 146.48
Book Value(Adj)-Unit Curr 263.66 439.45 527.34 234.37 175.78 146.48

Shareholding Pattern

  • Promoter Group

    51.82%

  • Public Share Holding

    48.18%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 17,833,646 17,833,646.00 17,833,646 17,833,646
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 17,833,646 3.07 17,833,646 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 212,567,649 36.60 212,567,649 4
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 70,547,426 12.15 70,547,426 9
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 283,115,075 48.75 283,115,075 13
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 27,330 0.00 27,330 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 1,210 0.00 1,210 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 94,615,551 16.29 94,615,551 648
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 29,719,083 5.12 29,719,083 22
Mutual Funds / UTI 103,427,976 17.81 103,427,976 33
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 13,226,840 2.28 13,226,840 24
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 241,017,990 41.50 241,017,990 730
2] Non Institution
Bodies Corporate 2,699,206 0.46 2,698,096 1,488
Clearing Members 9,100 0.00 9,100 10
Directors of their Relatives 4,010 0.00 4,010 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,339,524 0.40 2,339,524 8,087
Foreign Non Institution Other 410 0.00 410 1
Hindu Undivided Families 804,387 0.14 804,387 3,800
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,659,115 0.29 1,659,115 5
Individuals holding nominal share capital up to Rs. 1 lakh 30,395,586 5.23 29,719,754 243,812
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 16,993 0.00 16,993 9
Others 906,581 0.16 906,581 4
Sub Total 38,834,912 6.69 38,157,970 257,218
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 580,801,623 100.00 580,124,681 257,962

Company Background

Aurobindo Pharma LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Aurobindo Pharma Ltd
  • BSE Code : 4666.0
  • ISIN : INE406A01037

  • Incorporation Year

    1986

  • Registered Office

    Plot No 2 Maitrivihar
    Behind Maithri Vanam Ameerpet, Hyderabad,
    Telangana-500038

  • Telephone

    91-40-23736370

  • FAX

    91-40-23747340

  • Chairman

    M R Kumar

  • Managing Director

  • Company Secretary

  • Auditor

    Deloitte Haskins & Sells

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Aurobindo Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Aurobindo Pharma 1,134.85 11,261.70 10,645.64 34.68 11.74
Abbott India 30,305.85 6,097.18 5,848.91 48.26 44.71
Astrazeneca Phar 8,518.55 1,330.33 1,295.53 219.61 33.26
P & G Health Ltd 5,152.30 1,166.89 1,151.26 36.15 39.76
Glaxosmi. Pharma 2,793.40 3,530.73 3,407.25 55.55 44.44
Cipla 1,444.55 17,645.00 16,574.34 24.77 20.10
Amrutanjan Healt 642.85 437.58 421.23 37.68 20.84
Fermenta Biotec. 285.30 315.24 307.09 27.04 4.10
Guj. Themis Bio. 271.85 174.19 169.82 56.28 44.82
Bliss GVS Pharma 119.25 638.96 605.46 27.29 11.19
Ambalal Sarabhai 36.15 11.70 3.81 15.45 1.92